Zobrazeno 1 - 10
of 12
pro vyhledávání: '"M. J. Langhi"'
Autor:
S. Amato, Juan M. Romero Acuna, Luis Flores Acosta, Eduardo H. Ortiz, A Romero, M Machiavelli, Maria Ester Dominguez, Nora Marrone, Hebe Margot Fasce, M. J. Langhi, Carlos Teodoro Vallejo, Luis A. Romero Acuña, J E Perez, Fabrina Bologna, J. A. Lacava, Bernardo Amadeo Leone
Publikováno v:
American Journal of Clinical Oncology. 25:383-387
A phase II trial was performed to evaluate the efficacy and toxicity of the novel combination of vinorelbine and paclitaxel as first-line chemotherapy in patients with stages IIIB and IV non-small-cell lung cancer. From January 1997 to September 1999
Biochemical Modulation of 5-Fluorouracil by Methotrexate in Patients With Advanced Gastric Carcinoma
Autor:
Eduardo H. Ortiz, J E Perez, R. Rodriguez, Bernardo Amadeo Leone, Carlos Teodoro Vallejo, M. R. Barbieri, Luis A. Romero Acuña, Maria Ester Dominguez, M Machiavelli, A Romero, J. A. Lacava, Juan M. Romero Acuna, M. J. Langhi
Publikováno v:
American Journal of Clinical Oncology. 21:452-457
A phase II trial was conducted to evaluate the efficacy and toxicity of a modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) (with leucovorin (LV) rescue) as first-line chemotherapy in patients with locally advanced (inoperable) or metastatic
Autor:
Bernardo Amadeo Leone, J. M. Romero Acuna, M A Cuevas, L. Romero Acuna, M Machiavelli, Vito Lorusso, S. Amato, M. R. Barbieri, A Romero, M. J. Langhi, E. H. Ortiz, R. Rodriguez, Manuel Domínguez, M. A. Salvadori, J E Perez, M. DeLena, Carlos Teodoro Vallejo, C. L. Sabatini, J. A. Lacava
Publikováno v:
American Journal of Clinical Oncology. 21:94-98
A phase II trial was performed to evaluate the efficacy and toxicity of a double modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) and L-leucovorin (L-LV) in patients with advanced recurrent (inoperable) or metastatic colorectal carcinoma (AC
Autor:
R. Rodriguez, M A Cuevas, C. L. Sabatini, J. A. Lacava, Bernardo Amadeo Leone, L A Acuña, M Machiavelli, Maria Ester Dominguez, M. A. Salvadori, E. H. Ortiz, Carlos Teodoro Vallejo, J M Acuña, M. J. Langhi, M R Barbieri, S. Amato, J E Perez, A Romero
Publikováno v:
Journal of Clinical Oncology. 14:2993-2999
PURPOSE To evaluate the efficacy and toxicity of the combination of ifosfamide (IFX) and vinorelbine (VNB) as first-line chemotherapy in metastatic breast cancer (MBC). PATIENTS AND METHODS Between August 1993 and August 1995, 45 patients with untrea
Autor:
C. T. Vallejo, M. G. Rabinovich, J. E. Perez, R. Rodriguez, M. R. Machiavelli, B. A. Leone, A. D. Romero, J. A. Lacava, M. A. Cuevas, M. J. Langhi, L. A. Romero Acuna, J. Romero Acuna, S. Amato, M. R. Barbieri
Publikováno v:
American Journal of Clinical Oncology. 18:185-188
From March 1991 to October 1992, 41 patients with advanced non-small cell lung cancer (NSCLC) (20 stage IIIB and 21 stage IV) received a regimen consisting of cisplatin (CP) 100 mg/m2 i.v. days 1 and 8, and dipyridamole (DPD) 100 mg p.o. 75 minutes b
Autor:
Luis A. Romero Acuña, Maria Ester Dominguez, A Romero, M. J. Langhi, M. R. Barbieri, M Machiavelli, Mirna Scenna, Focaccia G, J E Perez, Carlos Teodoro Vallejo, J. A. Lacava, Eduardo H. Ortiz, R. Rodriguez, Sergio Grasso, Bernardo Amadeo Leone, Guillermo Suttora, Juan M. Romero Acuna, S. Amato, José M. Boughen
Publikováno v:
American journal of clinical oncology. 23(5)
A phase II trial was performed to assess the efficacy and toxicity of a combination of ifosfamide (IFX), cisplatin (CDDP), and vinorelbine (VNB) as neoadjuvant chemotherapy (NAC) for untreated advanced cervical carcinoma (ACC). Between October 1995 a
Autor:
M. A. Barbieri, Carlos Teodoro Vallejo, J. M. Romero Acuna, Hebe Margot Fasce, E. H. Ortiz, L. Romero Acuna, S. Grasso, M. J. Langhi, Bernardo Amadeo Leone, J E Perez, R. Rodriguez, M Machiavelli, S. Amato, A Romero, J. A. Lacava
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(1)
PURPOSE: To evaluate the efficacy and toxicity of a combination of vinorelbine (VNB) and paclitaxel (PTX) as first-line chemotherapy in metastatic breast carcinoma (MBC). PATIENTS AND METHODS: Between August 1995 and August 1997, 49 patients with unt
Autor:
M. J. Langhi, Carlos Teodoro Vallejo, J. A. Lacava, J. M. Romero Acuna, M. R. Barbieri, J E Perez, R. Rodriguez, N. Marrone, Manuel Domínguez, Bernardo Amadeo Leone, A Romero, L. Romero Acuna, M Machiavelli, E. H. Ortiz, S. Amato
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 18(8)
A phase II trial was carried out by the Grupo Oncologico Cooperativo del Sur (G.O.C.S.) to assess the efficacy and toxicity of a biochemical modulation of 5-fluorouracil (5-FU) by i.v. pretreatment with interferon (IFN)-alpha2b in patients with advan
Autor:
M. J. Langhi, J R Acuña, M A Cuevas, Carlos Teodoro Vallejo, S. Amato, Bernardo Amadeo Leone, A Romero, Guillermo Suttora, Luis A. Romero Acuña, J. A. Lacava, Y L Elem, Ángel Arroyo, J E Perez, Focaccia G, Ferreyra R, M Machiavelli, M. A. Salvadori, Castaldi J
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 15(2)
PURPOSE To evaluate the efficacy and toxicity of vinorelbine (VNB) as single-agent neoadjuvant chemotherapy in advanced cervical carcinoma (ACC). PATIENTS AND METHODS Between December 1993 and October 1995, 43 untreated patients with stages IIB to IV
Autor:
Bernardo Amadeo Leone, M. J. Langhi, Carlos Teodoro Vallejo, E. H. Ortiz, M. A. Barbieri, J. M. Romero Acuna, C. L. Sabatini, M. A. Salvadori, A Romero, M Machiavelli, J. A. Lacava, M A Cuevas, R. Rodriguez, Manuel Domínguez, L. Romero Acuna, S. Amato, J E Perez
Publikováno v:
American journal of clinical oncology. 19(6)
We evaluated the efficacy and toxicity of the novel combination of ifosfamide (IFX) and vinorelbine (VNB) as first-line chemotherapy in patients with stage IIIB and IV non-small cell lung cancer (NSCLC). Between March 1993 and November 1994, 44 patie